Clean Science & Technology Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹299 Cr +22% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
CS

Clean Science & Technology Ltd

Q2 FY26Chemicals & Petrochemicals

Clean Science & Technology Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹245Cr
+2.9% YoY
+0.8% QoQ
Net profit
₹55Cr
−6.8% YoY
−21.4% QoQ
Margin
36%
−2 pp YoY
−5 pp QoQ
Price₹826
Market cap₹8.2K Cr
P/E35.1

The short version

HALS segment expected to continue growing quarter-on-quarter, with 25% volume growth already seen in Q2 and plans to increase capacity utilization and revenues over the next two quarters. HALS segment showing strong growth with 25% QoQ volume increase; expected to continue quarter-on-quarter growth, improving capacity utilization and revenues in next two quarters.

From Clean Science & Technology Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • HALS segment expected to continue growing quarter-on-quarter, with 25% volume growth already seen in Q2 and plans to increase capacity utilization and revenues over the next two quarters.
  • Performance Chemicals Unit 1 capacity started with ~1,000 tons per annum, aiming for clearer customer demand next quarter before scaling further.
  • Performance Chemicals Unit 2 facility scheduled to start water trials in April 2026 and commercial production by June 2026, with a 3-year ramp-up expected.
  • The company targets INR 300 crore revenue from 10,000 tons capacity in Performance Chemicals by FY28.
  • Domestic market (mainly HALS) grew 13% in H1 FY26; still room to expand customer base with 70-75% capacity utilization for food-grade antioxidants.
  • Growth in new products and markets (US, Europe, Vietnam, Middle East, South Africa) expected as product acceptance improves.

2 more points from Clean Science & Technology Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Clean Science & Technology Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Clean Science invested approximately INR 150 crores in the subsidiary (CFCL) during H1 FY26.
  • Performance Chemical 1 facility is undergoing chemical trials with commercialization expected within 3-4 weeks.
  • Performance Chemical 2 facility water trials to start in April with commercial production anticipated by June; ramp-up expected over approximately 3 years.
  • Capacity expansion of some food-grade antioxidants has been successfully completed.
  • A new product (hydroxychloroquine-related) with an installed capacity of about 10,000 tons aims to generate approximately INR 300 crores revenue by FY28.

2 more points from Clean Science & Technology Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Clean Science & Technology Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company has started commercial samples for Performance Chemical One with less than 1,000 tons per annum of existing capacity utilized through refurbishment.
  • Full installed capacity for Performance Chemical One is about 10,000 tons, with revenue potential of around INR 300 crores by FY 2028.
  • Commercialization of barbituric acid successfully completed by repurposing existing facilities.
  • Capacity expansions have been done for some food-grade antioxidants.
  • Sales for Performance Chemical One and barbituric acid expected to gather momentum with increasing approvals and validations over coming quarters.
  • Sales volumes for HALS products growing sequentially at 25% volume and 34% value growth.

2 more points from Clean Science & Technology Ltd's call on order book

Create a free account to keep reading this call

Clean Science & Technology Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Clean Science & Technology Ltd Q2 FY26 results — key figures

Clean Science & Technology Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue245238+2.9%243+0.8%
Operating profit (EBITDA)8790-3.3%100-13%
Operating margin36%38%-2 pp41%-5 pp
Profit before tax7583-9.6%95-21.1%
Net profit (PAT)5559-6.8%70-21.4%
EPS (₹)5.225.53-5.6%6.59-20.8%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹299 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Gujarat Alkalies (Q2 FY26)

    2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against

  • Dynemic Products (Q2 FY26)

    Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a

  • Platinum Industr (Q2 FY26)

    Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri

  • IVP (Q2 FY26)

    Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Clean Science & Technology Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Clean Science & Technology Ltd Q2 FY26 results?

HALS segment expected to continue growing quarter-on-quarter, with 25% volume growth already seen in Q2 and plans to increase capacity utilization and revenues over the next two quarters. HALS segment showing strong growth with 25% QoQ volume increase; expected to continue quarter-on-quarter growth, improving capacity utilization and revenues in next two quarters.

What is Clean Science & Technology Ltd share price analysis?

Clean Science & Technology Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹8,173 Cr. Investors should review the full earnings analysis for detailed insights.

Is Clean Science & Technology Ltd planning capital expenditure?

Clean Science invested approximately INR 150 crores in the subsidiary (CFCL) during H1 FY26.

Keep Clean Science & Technology Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.